Company · CIK 0001395064 · SIC 2834 — Pharmaceutical Preparations · NYSE
TAKEDA PHARMACEUTICAL CO LTD · TAK
Insider activity reported against this company. All insider holders · Files at: MYOV, MTEM. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 15, 9:12 pm EDT | Lauren Rusckowski DupreyChief Transformation Officer | 34,535 | $18.54 | $640,279 | 191,522 | −15.3% | |
| Sep 2, 2026 SForm 4 → | Sep 3, 9:49 pm EDT | Andrew Stewart PlumpPresident, R&D, Director | 116,191 | $18.49 | $2,148,372 | 145,465 | −44.4% | 10b5-1 |
| Aug 19, 2026 SForm 4 → | Aug 21, 4:30 pm EDT | Andrew Stewart PlumpPresident, R&D, Director | 19,651 | $18.49 | $363,347 | 261,656 | −6.99% | 10b5-1 |
| Aug 18, 2026 SForm 4 → | Aug 19, 4:15 pm EDT | Nicola Deidre Petal GreenwayChief Human Resources Officer | 12,980 | $18.11 | $235,118 | 40,049 | −24.5% | |
| Aug 11, 2026 SForm 4 → | Aug 12, 4:10 pm EDT | Elaine Mary ShannonPres., Global Supply & Quality | 20,363 | $17.55 | $357,371 | 67,311 | −23.2% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:54 pm EDT | Awny Samaan Botros FarajallahChief Medical Officer | 14,006 | $17.10 | $239,503 | 116,177 | −10.8% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:53 pm EDT | Ramy Riad Ahmed IbrahimPresident, PDT BU | 7,277 | $17.10 | $124,437 | 102,588 | −6.62% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:53 pm EDT | Rhonda Janice PachecoPresident, U.S. Business Unit | 16,901 | $17.10 | $289,007 | 182,507 | −8.48% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:51 pm EDT | Lauren Rusckowski DupreyChief Transformation Officer | 47,586 | $17.10 | $813,721 | 226,057 | −17.4% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:50 pm EDT | Andrew Stewart PlumpPresident, R&D, Director | 165,393 | $17.10 | $2,828,220 | 766,569 | −17.7% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:46 pm EDT | Agosti Marcello PignagnoliHead, Strat. & Port. Dev | 22,957 | $17.10 | $392,565 | 176,977 | −11.5% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:45 pm EDT | Teresa Marie BitettiPresident, OBU | 50,012 | $17.10 | $855,205 | 252,010 | −16.6% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:42 pm EDT | Elaine Mary ShannonPres., Global Supply & Quality | 3,978 | $17.10 | $68,024 | 63,333 | −5.91% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:39 pm EDT | Gabriele RicciChief Data & Tech. Officer | 25,088 | $17.10 | $429,005 | 171,654 | −12.8% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:28 pm EDT | Nicola Deidre Petal GreenwayChief Human Resources Officer | 6,774 | $17.10 | $115,835 | 53,029 | −11.3% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:27 pm EDT | Julie So-Young KimPresident and CEO, Director | 89,090 | $17.10 | $1,523,439 | 391,489 | −18.5% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:25 pm EDT | Giles Richard PlatfordPresident, IBU | 31,083 | $17.10 | $531,519 | 315,838 | −8.96% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 9:23 pm EDT | Natalie Anne Marie FurneyGlobal General Counsel | 30,868 | $17.10 | $527,843 | 204,298 | −13.1% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 4:10 pm EDT | Nicola Deidre Petal GreenwayChief Human Resources Officer | 34,603 | $17.51 | $605,778 | 59,803 | −36.7% | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:29 pm EDT | Steven GillisDirector | 3,800 | — | — | 10,400 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:28 pm EDT | John MaraganoreDirector | 3,800 | — | — | 10,400 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:28 pm EDT | Kimberly A. ReedDirector | 3,800 | — | — | 10,400 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:14 pm EDT | Masami IijimaDirector | 1,800 | — | — | 14,601 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:12 pm EDT | Bruce D BroussardDirector | 3,800 | — | — | 4,595 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:11 pm EDT | Paulus StoffelsDirector | 3,800 | — | — | 3,800 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:10 pm EDT | Koichiro KimuraDirector | 1,800 | — | — | 1,800 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:10 pm EDT | Miki TsusakaDirector | 1,800 | — | — | 8,200 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:09 pm EDT | Asuka MiyabashiraPresident, Japan Pharma B.U. | 1,500 | — | — | 4,500 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:09 pm EDT | Milano FurutaChief Financial Officer, Director | 12,300 | — | — | 70,200 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:08 pm EDT | Giles Richard PlatfordPresident, IBU | 49,558 | — | — | 346,921 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:07 pm EDT | Jennifer Marie SmoterChief Comm. & Gov. Officer | 18,808 | — | — | 18,808 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:07 pm EDT | Ramy Riad Ahmed IbrahimPresident, PDT BU | 25,078 | — | — | 109,865 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:06 pm EDT | Nicola Deidre Petal GreenwayChief Human Resources Officer | 22,570 | — | — | 94,406 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:06 pm EDT | Awny Samaan Botros FarajallahChief Medical Officer | 17,554 | — | — | 130,183 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:05 pm EDT | Natalie Anne Marie FurneyGlobal General Counsel | 43,886 | — | — | 235,166 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:05 pm EDT | Rhonda Janice PachecoPresident, U.S. Business Unit | 50,156 | — | — | 199,408 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:04 pm EDT | Agosti Marcello PignagnoliHead, Strat. & Port. Dev. | 27,586 | — | — | 199,934 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:04 pm EDT | Gabriele RicciChief Data & Tech. Officer | 37,616 | — | — | 196,742 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:03 pm EDT | Elaine Mary ShannonPres., Global Supply & Quality | 30,094 | — | — | 87,674 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:03 pm EDT | Lauren Rusckowski DupreyChief Transformation Officer | 45,140 | — | — | 273,643 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:02 pm EDT | Teresa Marie BitettiPresident, OBU | 43,886 | — | — | 302,022 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:02 pm EDT | Julie So-Young KimPresident and CEO, Director | 73,234 | — | — | 22,800 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:01 pm EDT | Andrew Stewart PlumpPresident, R&D, Director | 125,390 | — | — | 931,962 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 ADForm 4 → | Jul 6, 6:29 pm EDT | Steven GillisDirector | 2,471 | $4,931.20 | $5,680,742 | 1,319 | — | |
| Jul 1, 2026 ADForm 4 → | Jul 6, 6:28 pm EDT | John MaraganoreDirector | 2,471 | $4,931.20 | $5,680,742 | 1,319 | — | |
| Jul 1, 2026 ADForm 4 → | Jul 6, 6:28 pm EDT | Kimberly A. ReedDirector | 2,471 | $4,931.20 | $5,680,742 | 1,319 | — | |
| Jul 1, 2026 ADForm 4 → | Jul 6, 6:14 pm EDT | Masami IijimaDirector | 4,089 | $4,931.20 | $10,611,942 | 1,937 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:12 pm EDT | Bruce D BroussardDirector | 1,319 | — | — | 1,319 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:11 pm EDT | Paulus StoffelsDirector | 1,307 | — | — | 1,307 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:10 pm EDT | Koichiro KimuraDirector | 1,937 | — | — | 1,937 | — | |
| Jul 1, 2026 ADForm 4 → | Jul 6, 6:10 pm EDT | Miki TsusakaDirector | 4,089 | $4,931.20 | $10,611,942 | 1,937 | — | |
| Jul 1, 2026 ADForm 4 → | Jul 6, 6:09 pm EDT | Asuka MiyabashiraPresident, Japan Pharma B.U. | 3,016 | $4,931.40 | $5,039,891 | 666 | — | |
| Jul 1, 2026 ADForm 4 → | Jul 6, 6:09 pm EDT | Milano FurutaChief Financial Officer, Director | 29,483 | $4,931.50 | $81,956,599 | 4,288 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:02 pm EDT | Julie So-Young KimPresident and CEO, Director | 23,225 | — | — | 7,743 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.